Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PANW vs GSK✓SelectedUSD · GSKPANW vs GSK performance historyLatest closeAs of+6.42%11/19
Stock and ETF performance explorer

PANW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,247.6%
GSK return
+97.7%
Excess return
+1,149.9%
Maximum drawdown
-48.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+6.4%-1.6%+8.0%+6.7%
7D+12.1%-4.7%+16.8%+13.1%
30D+6.3%-4.7%+11.0%+7.2%
3M+0.5%-8.8%+9.3%+2.2%
6M+50.6%-4.6%+55.3%+51.2%
YTD+96.4%+1.0%+95.4%+92.4%
1Y+81.0%+6.9%+74.1%+74.6%
3Y+192.2%+52.5%+139.7%+149.1%
5Y+309.2%+40.3%+269.0%+253.4%
All+1,247.6%+97.7%+1,149.9%+831.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling